CURRENT PHARMACY
CE TOPICS

CE PRN® Pharmacy Continuing Education Courses 2016

Current participants: Click on program ID# to read or download each lesson.
Click on the Buy button to purchase an individual lesson.
In order to obtain CE credit, you must purchase an individual lesson or the entire year course.

"Vaccines-Update" 707-000-16-011-H01-P (for Pharmacists); 707-000-16-011-H01-T (for Technicians) November/December (2.0 contact hours)

It is time to update & review information about vaccinations. This is a topic that you request most often. In this lesson it is our goal to present the vaccines/inoculations that are most important.buy-button

"Validation of Controlled Substances Prescriptions.". CE---Mandatory for Florida. 707-000-16-010-H03-P (for Pharmacists); 707-000-16-010-H03-T (for Technicians) October (2.0 contact hours for Florida Pharmacy Practitioners and 3.0 contact hours for participants enrolled in the cpeMonitor program)

IN THIS LESSON, we use the model that has been developed in Florida. It deals with modifications for dispensing of pain medications. Specifically, it is called VALIDATION OF PRESCRIPTIONS FOR CONTROLLED SUBSTANCES. IN THIS LESSON, WE DISCUSS ALL ASPECTS OF THIS NEW PROGRAM. ADDITIONALLY, WE REVIEW FEDERAL CONSIDERATIONS (ASPECTS OF THE FEDERAL CONTROLLED SUBSTANCES ACT) THAT INVOLVE DISTRIBUTION AND IMPACT DAILY PHARMACY PRACTICE.buy-button

“New Drugs of 2015-A Banner Year” 707-000-16-009-H01-P (for Pharmacists); 707-000-16-009-H01-T (for Technicians) September (3.0 contact hours)

This educational program will focus on some of the newer agents that are of interest to pharmacy. The goal is to provide key information relevant to dosing guidelines, common adverse effects, contraindications and significant counseling points.buy-button

“Pharmacogenetics of ADRs” 707-000-16-008-H01-P (for Pharmacists); 707-000-16-008-H01-T (for Technicians) August (1.5 contact hours)

This lesson highlights a few key, clinically relevant examples of ADRs with pharmacogenetic mechanisms. The goals of this lesson are to: explain the differences in drug response that may occur due to genetic variations of patients.buy-button

“Update: Hyperlipidemia” 707-000-16-007-H01-P (for Pharmacists); 707-000-16-007-H01-T (for Technicians) July (1.25 contact hours)

So many patients are taking cholesterol medications that it’s imperative to review this whole topic periodically. It reinforces one of the primary areas where we consult patients. The goals of this lesson are to: differentiate treatment options, and review newer medications.buy-button

“Update: Gout” 707-000-16-006-H01-P (for Pharmacists); 707-000-16-006-H01-T (for Technicians) June (1.25 contact hours)

We periodically review & update consideration of gout for two reasons: First: it is the most common inflammatory joint disease; 2nd—because the number of prescriptions for treating gout are on the increase. Our goals are to revisit this important topic & review treatment options.buy-button

“Medication Adherence” 707-000-16-005-H01-P (for Pharmacists); 707-000-16-005-H01-T (for Technicians) May (1.25 contact hours)

Non-adherence is such an important consideration in today’s healthcare environment. And as pharmacy professionals, we can and MUST take a lead role in improving adherence. The goal of this lesson is to focus on reviewing and updating strategies to improve adherence.buy-button

“New Oral Anticoagulants” 707-000-16-004-H01-P (for Pharmacists); 707-000-16-004-H01-T (for Technicians) April (1.25 contact hours)

For many years warfarin was the primary choice for anticoagulant therapy. Now there are a number of newer oral anticoagulants (NOACs) that have been approved by the FDA. In this lesson we review these. Our goal is to discuss therapeutic options.buy-button

“New Antimicrobials” 707-000-16-003-H01-P (for Pharmacists); 707-000-16-003-H01-T (for Technicians) March (1.25 contact hours)

Drug resistant infections are becoming more and more prevalent. In recent years, six new antimicrobials have been FDA-approved that have the potential to be used for these drug-resistant infections.buy-button

“Review COPD: Therapeutic Options” 707-000-16-002-H01-P (for Pharmacists); 707-000-16-002-H01-T (for Technicians) February (1.25 contact hours)

Chronic obstructive pulmonary disease (COPD) is a term used to describe a group of progressive, chronic, debilitating, noncontagious, and irreversible pulmonary inflammatory diseases characterized by obstruction of airflow in the lungs thereby making breathing difficult. In the U.S. the term refers to two disorders: emphysema and chronic bronchitis. However, in some medical circles refractory bronchial asthma is included. In this lesson we discuss significant therapeutic options.buy-button

“SHINGLES: Pharmacy Perspective” 707-000-16-001-H01-P (for Pharmacists); 707-000-16-001-H01-T (for Technicians) January (1.25 contact hours)

Shingles (Herpes Zoster) is a nerve infection caused by the varicella-zoster virus. It is this same virus that causes chicken pox. This is a common public health issue that seems to becoming more and more common. Pharmacy practitioners are in a unique place to provide critical information to patients. In this lesson we discuss the significance of therapies.buy-button

 

 

logo CPE Monitor